Cargando…
Pitavastatin approved for treatment of primary hypercholesterolemia and combined dyslipidemia
Pitavastatin was first developed in Japan and is expanding the regions in which it is clinically available. A considerable number of clinical studies have been conducted and published to date on the usefulness of pitavastatin for patients with primary hypercholesterolemia or combined dyslipidemia. P...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988623/ https://www.ncbi.nlm.nih.gov/pubmed/21127702 http://dx.doi.org/10.2147/VHRM.S7802 |